Stock screenerAll disclosures →
EDGAR →
REGN
Conviction 90HealthcareScan · Thu, Sep 24, 2026Regeneron Pharmaceuticals, Inc. (REGN) closed at $795.60 (-0.78%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 51, RS Rating 91, -6.6% from its 52-week high, +2.5% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
REGN$795.60-0.78%
ResistanceSupportVol 14Insider sellCongress buyCongress sell2
Vol MA14 769.61K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price795.60
Change-0.78%
Gap-0.06%
Rel volume1.91×
Avg volume742.63K
Avg $ vol594.98M
SMA 20802.85
SMA 50774.60
SMA 200735.26
Price vs 50+2.71%
Price vs 200+8.21%
MA stackbullish
50/200 cross—
Supertrenddown · 833.55
RSI (14)51
MACD hist-3.13
MACD cross—
Stoch %K / %D36 / 37
ADX (14)23
+DI / −DI25 / 18
RSI divergenceBearish
MACD divergenceBearish
ATR %2.41%
ADR %2.29%
52w high852.03
52w low555.51
From 52w high-6.62%
Above 52w low+43.22%
New 52w highNo
SqueezeOff
Bollinger width10.06%
%B0.41
Donchian pos28.99%
Donchian high859.34
Donchian low769.57
AVWAP (52w high)796.89
vs AVWAP high-0.16%
AVWAP (52w low)713.05
vs AVWAP low+11.58%
OBV trendDown
Chaikin MF (20)0.02
Today vs 20d1.91×
Avg vol (14d)769.61K
Avg vol (20d)742.63K
Avg $ vol (20d)594.98M
Market cap74.75B
RS Rating91 / 99
RS 3m (vs SPY)+23.80%
RS 6m (vs SPY)-10.66%
RS line new highNo
Trend template6/8
Technical rank67.2
1 week+0.78%
1 month-4.55%
3 months+28.29%
6 months+6.16%
1 year+40.10%
YTD+2.48%
P/E16.59
P/B2.36
P/S5.21
P/FCF18.32
EPS41.48
Div yield0.50%
ROE14.21%
ROA10.80%
Debt/Eq0.11
Current3.34
EV/EBITDA18.39
Gross margin—
Net margin31.41%
Rev growth0.99%
EPS growth2.09%
Price target843.47
Target upside6.02%
Analyst ratingBuy
Institutional100.61%
Ent. value75.78B
Revenue4.29B
Net income1.3B
Gross profit—
Free cash flow4.08B
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out103.02M
Employees15.41K
ListedTue, Apr 2, 1991
Free float98.32M
Float %94.6%
Short interest2.55M
Days to cover3.9d
Short volume46.3%
Squeeze score42 / 100
Next earnings—
EPS forecast—
Last EPS vs est$12.53 vs $8.00
Last surprise+56.6% beat
Setup gradeA+
Conviction90 / 100
Pattern quality—
Tech rank67.2 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance853.17
Support774.33
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in REGN · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Alan Armstrong senate · R · OK · traded 2026-03-27 | Buy | $1K–$15K | 2026-03-27 | 2026-07-21 | |
 Gilbert Cisneros house · CA · traded 2026-05-15 | Sell | $1K–$15K | 2026-05-15 | 2026-06-05 | |
Gilbert Cisneros house · CA · traded 2025-11-18 | Buy | $1K–$15K | 2025-11-18 | 2025-12-12 | |
 Rob Bresnahan house · PA · traded 2025-05-15 | Buy | $1K–$15K | 2025-05-15 | 2025-06-09 | |
 Byron Donalds house · R · FL · traded 2025-04-10 | Sell | $1K–$15K | 2025-04-10 | 2025-05-24 | |
 Julie Johnson house · D · TX · traded 2025-04-01 | Sell | $1K–$15K | 2025-04-01 | 2025-05-14 | |
 Jefferson Shreve house · R · IN · traded 2025-04-07 | Sell | $15K–$50K | 2025-04-07 | 2025-05-08 | |
Rob Bresnahan house · PA · traded 2025-04-08 | Sell | $1K–$15K | 2025-04-08 | 2025-05-08 | |
Rob Bresnahan house · PA · traded 2025-02-25 | Sell | $1K–$15K | 2025-02-25 | 2025-03-27 | |
Julie Johnson house · D · TX · traded 2025-02-12 | Sell | $1K–$15K | 2025-02-12 | 2025-03-12 |
Insider activity
SEC Form 4 transactions in REGN · open-market 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
LAROSA JOSEPH J EVP General Counsel and Secret · Common Stock · 2026-08-19 | Exercise | 12.28K | $4.7M | 2026-08-19 | 2026-08-21 |
LAROSA JOSEPH J EVP General Counsel and Secret · Common Stock · 2026-08-19 | Tax | 9.02K | $7.5M | 2026-08-19 | 2026-08-21 |
LAROSA JOSEPH J EVP General Counsel and Secret · Non-Qualified Stock Option (right to buy) · 2026-08-19 | Exercise | 12.28K | — | 2026-08-19 | 2026-08-21 |
Fenimore Christopher R. EVP Finance CFO · Non-Qualified Stock Option (right to buy) · 2026-08-18 | Exercise | 6.28K | — | 2026-08-18 | 2026-08-20 |
Fenimore Christopher R. EVP Finance CFO · Common Stock · 2026-08-18 | Exercise | 6.28K | $2.4M | 2026-08-18 | 2026-08-20 |
Fenimore Christopher R. EVP Finance CFO · Common Stock · 2026-08-18 | Tax | 4.6K | $3.7M | 2026-08-18 | 2026-08-20 |
Guarini Kathryn Director · Common Stock · 2026-08-10 | Exercise | 400 | $288K | 2026-08-10 | 2026-08-12 |
Guarini Kathryn Director · Common Stock · 2026-08-10 | Sell | 400 | $320K | 2026-08-10 | 2026-08-12 |
Guarini Kathryn Director · Non-Qualified Stock Option (right to buy) · 2026-08-10 | Exercise | 400 | — | 2026-08-10 | 2026-08-12 |
Zoghbi Huda Y Director · Common Stock · 2026-08-10 | Exercise | 800 | $301K | 2026-08-10 | 2026-08-12 |
SEC filings
EDGAR filings in REGN · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.